pfizer (australia) sodium chloride 0.9% (900mg/100ml) iv infusion
pfizer australia pty ltd - sodium chloride, quantity: 900 mg - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - for the restoration and maintenance of salt and extracellular fluid levels or as a vehicle for the administration of parenteral drugs.
pfizer (australia) sodium chloride 0.9% (450mg/50ml) intravenous infusion
pfizer australia pty ltd - sodium chloride, quantity: 450 mg - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for the restoration and maintenance of salt and extracellular fluid levels or as a vehicle for the administration of parenteral drugs.
sunitinib pfizer
pfizer new zealand limited - sunitinib malate 16.7mg equivalent to sunitinib 12.5mg; - capsule - 12.5 mg - active: sunitinib malate 16.7mg equivalent to sunitinib 12.5mg excipient: croscarmellose sodium gelatin ink iron oxide red magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma
sunitinib pfizer
pfizer new zealand limited - sunitinib malate 33.4mg equivalent to sunitinib 25mg; - capsule - 25 mg - active: sunitinib malate 33.4mg equivalent to sunitinib 25mg excipient: croscarmellose sodium gelatin ink iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma
sunitinib pfizer
pfizer new zealand limited - sunitinib malate 50.1mg equivalent to sunitinib 37.5mg; - capsule - 37.5 mg - active: sunitinib malate 50.1mg equivalent to sunitinib 37.5mg excipient: croscarmellose sodium gelatin ink iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma
sunitinib pfizer
pfizer new zealand limited - sunitinib malate 66.8mg equivalent to sunitinib 50mg; - capsule - 50 mg - active: sunitinib malate 66.8mg equivalent to sunitinib 50mg excipient: croscarmellose sodium gelatin ink iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma
exemestane pfizer
pfizer australia pty ltd - exemestane -
exemestane pfizer
pfizer australia pty ltd - exemestane -
pfizer-biontech covid-19 vaccine, bivalent- original and omicron ba.4/ba.5 injection, suspension
pfizer manufacturing belgium nv - tozinameran (unii: 5085zfp6sj) (tozinameran - unii:5085zfp6sj), bnt162b2 omicron (ba.4/ba.5) (unii: jsv288q5cv) (bnt162b2 omicron (ba.4/ba.5) - unii:jsv288q5cv) -
pfizer-biontech covid-19 vaccine suspension for injection
pfizer saudi limited, saudi arabia - bnt162b2 - suspension for injection - 30 µg